Strengthening Patient-Surgeon Communication

by Columbia Surgery on June 13, 2013

170083396The time before a surgery can be fraught with stressors  – but communication between you and your surgeon should not be one. New apps are being designed to help overcome the medical language barrier, reconciling the fracture between surgical jargon and patient understanding by providing the doctor with interactive, visual aids.

Made for the iPad, drawMD is an educational tool where doctors can sit alongside their patients and explain a medical diagnosis or surgical procedure using interactive diagrams. Using the iPad’s hands-on interface, the app provides the physician with the anatomy space (i.e.: chest cavity, abdomen, etc.) and the ability to drag and drop relevant anatomical and surgical instruments (i.e.: cysts, tumors, scalpels, etc.) as well as draw and submit text directly onto the image. If the image the doctor requires doesn’t pre-exist within the app? The doctor can simply upload his own. From there, doctors can save, print, and share these images with the patients so they can discuss with their family members and other loved ones.

Some examples of the specialties available for drawMD include:

drawMD provides a way to help your surgeon translate the medical-speak into concrete, comprehendible images, enabling you to thoroughly understand your procedure and hopefully in doing so, giving you a sense of security in the course of action you both have decided. As we have spoken about in a previous blog, Alleviating Surgical Anxiety with your Smartphone, you should above all feel comfortable with your surgical decision. Be sure to work with your surgeon to understand your diagnosis and be comfortable in your action plan.

{ 0 comments }

lung_brochure copyIf you are a medical professional involved with the management of patients with lung cancer, be sure to attend the 2013 Lung Cancer CME: Updates and Challenges in Lung Cancer Friday, June 21.

This one-day CME accredited educational course will focus on challenging aspects of lung cancer care as well as updates on screening, work-up, diagnosis, staging and treatment. In the following interview, we spoke with Balazs Halmos, MD, Program co-director, to learn about what to expect at this year’s conference.

Q: What type of innovations and discoveries within lung cancer clinical trials and research will be covered at this year’s conference?

Dr. Halmos: This year’s CME will cover a range of topics such as lung cancer screening, detection, and staging. Perhaps most importantly it will discuss the exciting findings of the different conferences and current clinical studies in the field. One of the CME’s highlights will be a presentation on the updates from the recent ASCO conference. The ASCO conference included a number of key presentations, such as the new genetic abnormalities identified in different types of lung cancers that will facilitate personalized treatments for patients as well as remarkable advances in the field of immunotherapy for lung cancer. We are excited to be able to discuss all of this with our attendees.

Q: How have diagnostic procedures such as electromagnetic navigation bronchoscopy changed the playing field for the diagnosis and staging of lung cancer? How will this be addressed in the CME?

Dr. Halmos: Recently we have seen major advances in our ability to obtain tissue biopsies from difficult-to-reach areas, which is critical for the appropriate diagnosis and staging of lung cancer. In the past, lymph nodes were evaluated by an invasive surgical procedure.  In this year’s CME, we will cover major advances in the field of bronchoscopy, such as the use of an ultrasound device to help those bronchoscopies to reach lymph nodes in difficult areas like the middle of the chest or in the hilum. This allows us to better assess whether lymph nodes are affected by cancer with minimally invasive techniques, which is key in designing the best treatment plan. We will also review how the exciting novel technique of electromagnetic navigational bronchoscopy enables us to sample areas of the lung that were simply unreachable through the use of bronchoscopy in the past. Furthermore, we will discuss how we are able to use tiny samples obtained through these novel techniques sufficiently for the completion of specialized molecular testing to understand the genetic profile to tailor treatments for each patient.  These devices are now available at NYP and we are excited to share our expertise with our attendees at the event.

Q: Will personalized medicine be discussed at Updates and Challenges in Lung Cancer? If so, where will this be addressed?

Dr. Halmos: Personalized medicine will definitely be one of the highlights of the conference. Increased knowledge of the molecular and genetic makeup of lung tumors has given us better understanding why these cancer cells grow and which treatments can best target them, giving our patients the greatest chances of remission. Moreover, while we are better targeting these cancers, we are simultaneously limiting the adverse side effects of therapy as these targeted treatments have fewer systemic effects. While many of the CME lectures will touch on the topic of personalized medicine, we especially look forward to having Dr. Ramaswamy Govindan as one of our keynote speakers. Dr. Govindan has been one of the leaders of genomic medicine in the world and recently published findings of a large national effort that he has led, examining the entire DNA sequence of a number of lung cancers and giving us an accurate roadmap toward advancing personalized medicine for patients with lung cancer. I will also be providing an overview of molecular targeting as a biological therapy for lung cancer.

Q: Why is Updates and Challenges in Lung Cancer a must-attend CME? What makes this course unique as compared to other CME events in its field?

Dr. Halmos: Updates and Challenges in Lung Cancer is unique because it is one of the few CMEs that addresses all aspects of lung cancer with such a strong emphasis on the multidisciplinary nature of thoracic oncology.  First, we cover all the major fields involved with lung cancer medicine such as radiology, pulmonary, pathology, thoracic surgery, and medical oncology with expert speakers to address major advances in all the different fields. In addition, we have designed this conference to be centered on key case presentations to highlight the need for multidisciplinary management approaches in the treatment of any stage and type of lung cancer. Between the course’s multidisciplinary nature as well as the focus on case presentations, we hope to create an environment closer to clinicians’ day-to-day practice, focusing on what they’ll see in patient care rather than strictly research advances.

To watch this program live online, register on our Updates and Challenges in Lung Cancer live broadcast site.

For more information, please contact Jessica Scully, Program Coordinator, at 201.346.7007 or jas2134@columbia.edu

{ 0 comments }

Columbia HeartSource Program

June 7, 2013

Tweet “After all we are merely the servants of the public, in spite of our M.D.’s and our hospital appointments.” – Sir Henry Howarth Bashford It was 1997 when two Columbia surgeons were asked for some extraordinary health advice. In this instance it was not a patient request, but a hospital. This hospital had witnessed [...]

Read the full article →

Are You Dense?

June 4, 2013

Tweet Understanding the facts about mammography and dense breast tissue. Most women appreciate the importance of regular mammograms in detecting breast cancer at the earliest possible stage. In the last few years, new information has shed light on the value of knowing one’s breast density level, because density affects both risk for breast cancer as [...]

Read the full article →

Ravi P. Kiran, MBBS, Appointed Chief, Division of Colorectal Surgery

June 3, 2013

Tweet Please join the Department in welcoming Ravi P. Kiran, MBBS, MS, FRCS (Eng), FRCS (Glas), FACS, Msc EBM (Oxford), as Chief and Program Director, Division of Colorectal Surgery, as of June 1, 2013. Dr. Kiran is one of only a few surgeons nationwide who performs continent ileostomy reservoir procedures and other complex operations to [...]

Read the full article →

Organic or Not?

May 30, 2013

Tweet Deborah Gerszberg, RD, CNSC, CDN Clinical Nutritionist, The Pancreas Center To buy organic or not to buy organic? That is the question.  At least, that is the question I will attempt to answer for you in this blog. As the organic food sections in our grocery stores continue to expand, you may find yourself [...]

Read the full article →

Fast-track Evaluation for Adults with Congenital Heart Disease

May 17, 2013

Tweet One-of-a-kind program provides single-day evaluation and consultation with senior ACH specialists. Adults who had childhood surgery for Tetralogy of Fallot or pulmonary stenosis should continue to be evaluated to ensure that their hearts are functioning well and to determine whether any further treatment may be needed. But many do not have regular follow-up with [...]

Read the full article →

Alleviate Surgical Anxiety with Your Smartphone

May 15, 2013

Tweet Let’s be honest – most of us do not look forward to surgery. While we understand it’s the best option for our health and know we’re in the hands of amazing, well-qualified surgeons, the thought of an operation can send some of us into a panic. To alleviate their fear, some patients are looking [...]

Read the full article →

CT Lung Cancer Screening Program

May 13, 2013

Tweet Lung cancer screening with computed tomography (CT) effectively detects lung cancer at an early stage when it has the best chances of being fully removed and cured. Screening is performed before the onset of any symptoms; patients who exhibit any symptoms undergo diagnostic testing prescribed by their doctors. Based on the landmark National Lung [...]

Read the full article →

Vein Disease – When to Intervene and How

May 7, 2013

Tweet Vein disease and disorders of the veins affect nearly 80 million Americans. They include cosmetically displeasing spider veins, more serious conditions such as bulging varicose veins as well as life-threatening conditions such as Deep Vein Thrombosis (DVT). While some forms of vein disease are harmless, early detection is important, because even minor diseases can [...]

Read the full article →